BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1277456)

  • 1. Efficacy of activated charcoal hemoperfusion in removing lethal doses of barbiturates and salicylate from the blood of rats and dogs.
    Hill JB; Palaia FL; McAdams JL; Palmer PJ; Maret SM
    Clin Chem; 1976 Jun; 22(6):754-60. PubMed ID: 1277456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed-bed uncoated charcoal hemoperfusion in the treatment of intoxications: animal and patient studies.
    de Torrente A; Rumack BH; Blair DT; Anderson RJ
    Nephron; 1979; 24(2):71-7. PubMed ID: 492413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An activated charcoal hemoperfusion system for the treatment of barbital or ethylene glycol poisoning in dogs.
    Adaudi AO; Oehme FW
    Clin Toxicol; 1981 Sep; 18(9):1105-15. PubMed ID: 7318392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of activated charcoal on poisons in the digestive tract.
    Chin L; Picchioni AL; Duplisse BR
    Toxicol Appl Pharmacol; 1970 May; 16(3):786-99. PubMed ID: 5422220
    [No Abstract]   [Full Text] [Related]  

  • 5. Fixed-bed charcoal hemoperfusion. Treatment of drug overdose.
    Koffler A; Bernstein M; LaSette A; Massry SG
    Arch Intern Med; 1978 Nov; 138(11):1691-4. PubMed ID: 718320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salicylate removal by charcoal haemoperfusion in experimental intoxication in dogs:an assessment of efficacy and safety.
    Brookings CH; Ramsey JD
    Arch Toxicol; 1975 Nov; 34(3):243-52. PubMed ID: 1243624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rationale for fixed-bed charcoal in hemoperfusion.
    Hill JB; Palaia FL; McAdams JL; Palmer PJ; Skinner JT; Maret SM
    Kidney Int Suppl; 1976 Dec; (7):S328-32. PubMed ID: 1070556
    [No Abstract]   [Full Text] [Related]  

  • 8. Extracorporeal treatment of salicylate or acetaminophen poisoning--is there a role?
    Winchester JF; Gelfand MC; Helliwell M; Vale JA; Goulding R; Schreiner GE
    Arch Intern Med; 1981 Feb; 141(3 Spec No):370-4. PubMed ID: 7008736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine endotoxin shock.
    Bende S; Bertók L
    Circ Shock; 1986; 19(2):239-44. PubMed ID: 3719924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated charcoal in barbiturate and glutethimide poisoning of the dog.
    Fiser RH; Maetz HM; Treuting JJ; Decker WJ
    J Pediatr; 1971 Jun; 78(6):1045-7. PubMed ID: 5577187
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of charcoal hemoperfusion in dogs with acute fluoroacetamide poisoning].
    Gao Y; Chen YL; Deng HY; Zhong F; Li YJ
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):661-4. PubMed ID: 18021555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of alpha-amanitin from blood by hemoperfusion over uncoated charcoal. Experimental results.
    Masini E; Blandina P; Mannaioni PF
    Contrib Nephrol; 1982; 29():76-81. PubMed ID: 7075219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemoperfusion with coated activated charcoal for treating acute poisoning by remedies, plant protectants, and fungi. I. Remedies (author's transl)].
    Okonek S
    Med Klin; 1976 Jun; 71(26):1120-4. PubMed ID: 934007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluation of the use of activated charcoal in the treatment of acute poisoning.
    Corby DG; Fiser RH; Decker WJ
    Pediatr Clin North Am; 1970 Aug; 17(3):545-56. PubMed ID: 4395284
    [No Abstract]   [Full Text] [Related]  

  • 15. The thin-film adsorber hemoperfusion device: development and evaluation of clearance characteristics.
    Cooney DO; Kane RP
    Artif Organs; 1982 May; 6(2):151-62. PubMed ID: 7125957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of extrahepatic occlusive jaundice with activated charcoal hemoperfusion in dogs.
    Lie TS; Kim WI; Holst A; Grünn U; Rommelsheim K
    Acta Hepatogastroenterol (Stuttg); 1976; 23(4):262-6. PubMed ID: 970083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of uncoated activated carbon hemoperfusion in acute poisoning: in vitro studies.
    Tessore V; Luboz MP; Denti E
    Contrib Nephrol; 1982; 29():65-75. PubMed ID: 7075217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of acute salicylate poisoning].
    Herren T; Como F; Krähenbühl S; Wyss PA
    Schweiz Med Wochenschr; 1993 Sep; 123(38):1775-83. PubMed ID: 8211029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acute poisoning with activated charcoal.
    Corby DG; Decker WJ
    Pediatrics; 1974 Sep; 54(3):324-9. PubMed ID: 4606780
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of haemoperfusion with uncoated charcoal in the management of acute intoxications with barbiturate and salicylate.
    Fantozzi R; Martinelli F; Masini E; Sodi A; Amaducci L; Mannaioni P
    Subst Alcohol Actions Misuse; 1981; 2(1):55-62. PubMed ID: 7302803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.